Table 2.
The Medical Outcomes Study Short-Form 36 (SF-36) subscales and summary dimensions and utility scores in 2,633 patients with rheumatic diseases and 649 healthy controls
| Mean±SD | ||||||||||||||
| SF-36 SUB-SCALES | SF-36 DOMAINS | UTILITY SCORES | ||||||||||||
| n. | PF | RP | BP | GH | MH | RE | SF | VT | PCS | MCS | EQ-5D | SF-6D | EQ-VAS | |
| Healty controls | 649 | 88.9±13.3 | 88.7±21.7 | 82.9±17.3 | 63.4±17.4 | 65.7±15.0 | 76.1±34.5 | 77.3±18.1 | 59.6±15.4 | 57.4±11.3 | 54.4±13.6 | 0.81±0.1 | 0.78±0.31 | 75.8±11.0 |
| 1. Inflammatory rheumatic | ||||||||||||||
| Rheumatoid arthritis | 572 | 39.1±19.8 | 29.2±14.8 | 28.6±16.3 | 43.0±19.4 | 49.6±22.8 | 36.6±40.8 | 46.7±20.8 | 40.8±20.2 | 30.5±6.2 | 44.7±12.2 | 0.44±0.14 | 0.57±0.08 | 48.7±15.3 |
| Peripheral psoriatic arthritis | 150 | 46.9±21.2 | 32.5±23.2 | 38.1±19.0 | 45.6±18.1 | 49.7±20.3 | 33.0±36.0 | 48.0±22.2 | 47.3±18.0 | 34.8±6.7 | 41.3±11.3 | 0.51±0.15 | 0.60±0.08 | 54.0±14.1 |
| Ankylosing spondylitis | 251 | 52.3±20.2 | 38.4±28.1 | 44.3±17.4 | 47.3±20.9 | 53.5±20.9 | 43.09±30.5 | 52.2±19.4 | 47.1±19.2 | 36.9±8.1 | 40.7±10.1 | 0.55±0.14 | 0.62±0.75 | 57.4±14.4 |
| 2. Connective tissue disorders | ||||||||||||||
| Systemic sclerosis | 75 | 62.7±22.9 | 62.4±35.5 | 55.1±28.7 | 40.5±17.5 | 57.2±20.3 | 65.40±36.1 | 62.9±22.2 | 50.0±17.9 | 42.5±8.1 | 43.6±9.1 | 0.61±0.17 | 0.66±0.10 | 54.7±16.7 |
| Systemic lupus erythematosus | 83 | 69.2±19.4 | 37.65±37.7 | 48.9±22.3 | 39.8±17.3 | 53.3±20.6 | 47.7±40.7 | 55.9±22.7 | 43.1±17.8 | 42.0±12.5 | 46.1±16.6 | 0.58±0.15 | 0.61±0.10 | 50.5±11.5 |
| Sjogren syndrome | 50 | 80.3±19.3 | 71.5±33.5 | 71.5±26.3 | 58.8±19.2 | 60.7±19.2 | 67.2±41.2 | 69.5±22.5 | 50.0±17.9 | 50.8±12.6 | 49.2±15.2 | 0.74±0.17 | 0.71±0.10 | 62.8±14.0 |
| 3. Symptomatic peripheral osteoarthritis | ||||||||||||||
| Osteoarthritis of the knee | 176 | 46.1±21.8 | 33.1±32.1 | 44.5±15.4 | 45.6±18.0 | 54.7±19.3 | 46.9±39.6 | 55.4±24.2 | 47.4±18.9 | 42.9±17.0 | 50.8±19.5 | 0.53±0.16 | 0.62±0.09 | 56.1±15.6 |
| Osteoarthritis of the hip | 136 | 51.4±24.0 | 33.9±34.2 | 40.0±14.7 | 39.7±18.6 | 49.9±21.0 | 44.6±41.5 | 54.8±22.4 | 40.6±18.5 | 40.8±17.7 | 47.3±19.14 | 0.53±0.15 | 0.61±0.08 | 51.4±16.8 |
| Osteoarthritis of the hand | 87 | 77.7±14.8 | 67.3±28.8 | 72.5±17.7 | 56.9±16.7 | 66.5±15.8 | 83.6±25.1 | 73.8±17.2 | 55.1±15.4 | 45.9±7.0 | 53.6±8.7 | 0.76±0.10 | 0.72±0.06 | 69.1±10.3 |
| 4. Soft tissue disorders | ||||||||||||||
| Fibromyalgia | 226 | 49.9±17.3 | 17.2±35.0 | 35.5±9.7 | 34.4±11.1 | 36.8±13.3 | 36.7±23.9 | 36.4±13.8 | 38.2±12.1 | 38.8±4.7 | 32.3±7.5 | 0.45±0.11 | 0.56±0.05 | 45.9±11.6 |
| Low back pain | 141 | 61.2±23.7 | 39.5±34.4 | 45.1±19.2 | 47.5±19.9 | 54.6±19.5 | 50.9±36.8 | 57.6±22.6 | 44.2±17.5 | 47.1±19.5 | 51.7±18.0 | 0.61±0.16 | 0.65±0.85 | 62.5±18.1 |
| Shoulder pain | 112 | 55.3±23.6 | 35.7±35.9 | 43.1±17.3 | 41.9±14.6 | 54.9±13.7 | 50.3±43.6 | 56.2±15.2 | 48.5±13.4 | 44.0±14.5 | 52.4±16.0 | 0.56±0.12 | 0.63±0.06 | 53.4±14.3 |
| 5. Osteoporosis | ||||||||||||||
| Osteoporosis with vertebral fractures | 402 | 51.7±22.7 | 34.2±35.4 | 47.2±20.9 | 42.5±18.7 | 41.1±19.4 | 40.1±38.7 | 56.4±22.3 | 45.6±16.7 | 35.4±8.8 | 44.0±9.3 | 0.51±0.14 | 0.60±0.73 | 53.2±15.7 |
| Osteoporosis whitout fractures | 172 | 73.0±21.8 | 60.1±38.4 | 66.2±23.1 | 54.9±19.2 | 59.4±18.1 | 69.6±34.0 | 72.7±22.0 | 56.3±16.2 | 46.1±8.8 | 49.3±8.6 | 0.77±0.09 | 0.81±0.06 | 67.8±11.4 |
Abbreviations. SD = standard deviation; SF-36 = Medical Outcomes Study Short-Form 36 Health Survey; PF = physical functioning; RP = role limitations due to physical function; BP = bodily pain; GH = general health; MH = mental health; RE = role limitations due to emotional health; SF = social functioning; VT = vitality; PCS = physical component summary; MCS = mental component summary; EQ-5D = EuroQol five Dimensions questionnaire; SF-6D = Short-Form six Dimensions.